SC Filed 2018-04-12 Event — SEC 0001104659-18-023585 →

Roivant Sciences Ltd. → Arbutus Biopharma Corp ABUS

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 12/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: -4.2%

Filer track record (3 filings): 0% 90d win rate, -4.2% 90d edge
Moderate short days-to-cover (4.3 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

27 13D/G filings on this issuer

26 other filings besides this one

Filer Track Record

23 filings by this filer

22 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 4.34

24,566,591 shares short · -27.9% vs prior

Other 13D/G Filings on Arbutus Biopharma Corp

Filed	Form	Filer	Stake	Shares
2026-10-05	SCHEDULE 13D/A	Roivant Sciences Ltd.	19.50%	29,880,079	view →
2026-09-04	SCHEDULE 13G	Whitefort Capital Management, LP	—	—	view →
2026-04-28	SCHEDULE 13D/A	Whitefort Capital Management, LP	—	15,794,261	view →
2026-04-13	SCHEDULE 13D/A	Whitefort Capital Management, LP	8.10%	15,794,261	view →
2025-02-25	SCHEDULE	Roivant Sciences Ltd.	20.50%	38,847,462	view →
2025-02-21	SCHEDULE	Whitefort Capital Management, LP	7.00%	13,307,967	view →
2025-02-18	SCHEDULE	Roivant Sciences Ltd.	20.50%	38,847,462	view →
2021-10-20	SC	Roivant Sciences Ltd.	—	—	view →
2019-07-17	SC	Lo Andrew	—	—	view →
2019-07-17	SC	Machado Patrick	—	—	view →
2019-07-16	SC	Roivant Sciences Ltd.	—	—	view →
2019-07-12	SC	Dexxon Holdings Ltd.	—	—	view →
2019-07-12	SC	SVF Investments (UK) Ltd	—	—	view →
2019-07-12	SC	VIKING GLOBAL INVESTORS LP	—	—	view →
2019-07-12	SC	QVT Financial LP	—	—	view →
2019-01-03	SC	VIKING GLOBAL INVESTORS LP	—	—	view →
2018-04-23	SC	Roivant Sciences Ltd.	—	—	view →
2018-03-16	SC	Roivant Sciences Ltd.	—	—	view →
2018-02-14	SC	Roivant Sciences Ltd.	—	—	view →
2018-01-16	SC	Machado Patrick	—	—	view →

Showing 20 of 26

Other Filings by Roivant Sciences Ltd.

Filed	Form	Issuer	Stake	Shares
2026-10-05	SCHEDULE 13D/A	Arbutus Biopharma Corp	19.50%	29,880,079	view →
2025-02-25	SCHEDULE	Arbutus Biopharma Corp ABUS	20.50%	38,847,462	view →
2025-02-18	SCHEDULE	Arbutus Biopharma Corp ABUS	20.50%	38,847,462	view →
2025-01-15	SCHEDULE	Immunovant, Inc. IMVT	56.90%	96,660,341	view →
2023-10-04	SC	Immunovant, Inc. IMVT	—	—	view →
2021-10-20	SC	Arbutus Biopharma Corp ABUS	—	—	view →
2021-08-02	SC	Immunovant, Inc. IMVT	—	—	view →
2021-03-08	SC	Immunovant, Inc. IMVT	—	—	view →
2020-09-04	SC	Immunovant, Inc. IMVT	—	—	view →
2020-05-15	SC	Immunovant, Inc. IMVT	—	—	view →
2019-12-31	SC	Urovant Sciences Ltd.	—	—	view →
2019-12-31	SC	Axovant Gene Therapies Ltd.	—	—	view →
2019-12-31	SC	Myovant Sciences Ltd.	—	—	view →
2019-07-16	SC	Urovant Sciences Ltd.	—	—	view →
2019-07-16	SC	Arbutus Biopharma Corp ABUS	—	—	view →
2019-07-16	SC	Myovant Sciences Ltd.	—	—	view →
2019-07-16	SC	Axovant Gene Therapies Ltd.	—	—	view →
2019-03-19	SC	Axovant Sciences Ltd.	—	—	view →
2018-04-23	SC	Arbutus Biopharma Corp ABUS	—	—	view →
2018-03-16	SC	Arbutus Biopharma Corp ABUS	—	—	view →

Showing 20 of 22

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →